课题基金 / 基金详情

RECEPTOR-TARGETED PROTEIN TOXINS FOR BRAIN TUMOR THERAPY

RECEPTOR-TARGETED PROTEIN TOXINS FOR BRAIN TUMOR THERAPY
用于脑肿瘤治疗的受体靶向蛋白毒素
批准号:
2100836
负责人:
Nathan A. Berger
金额:
$16.03万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-04-01 至 1997-03-31

项目成果

Nathan A. Berger的其他基金

相似基金

相关文献

期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Expression of full-length trkB receptors by reactive astrocytes after chronic CNS injury.
慢性中枢神经系统损伤后反应性星形胶质细胞表达全长 trkB 受体。
DOI: 10.1006/exnr.1997.6698
发表时间: 1997
期刊: Experimental neurology.
影响因子: --
作者: [McKeon,RJ, Silver,J, Large,TH]
通讯作者: Large,TH
Expression of TrkB receptor isoforms in the developing avian visual system.
TrkB 受体亚型在发育中的鸟类视觉系统中的表达。
DOI: 10.1523/jneurosci.16-05-01740.1996
发表时间: 1996
期刊: The Journal of neuroscience : the official journal of the Society for Neuroscience.
影响因子: --
作者: [Garner,AS, Menegay,HJ, Boeshore,KL, Xie,XY, Voci,JM, Johnson,JE, Large,TH]
通讯作者: Large,TH
TeleHealth Resistance exercise Intervention to preserve dose intensity and Vitality in Elder breast cancer patients (THRIVE)
TeleHealth Resistance exercise Intervention to preserve dose intensity and Vitality in Elder breast cancer patients (THRIVE)
TeleHealth Resistance exercise Intervention to preserve dose intensity and Vitality in Elder breast cancer patients (THRIVE)
Case Comprehensive Cancer Center (Case CCC) Cancer Health Disparities SPORE Planning Grant
  • 批准号:
    10469702
  • 项目类别:
  • 资助金额:
    $39.86万
  • 财政年份:
    2018
  • 负责人:
    Nathan A. Berger
  • 依托单位:
国内基金
海外基金
柳枝稷miR156-targeted PvSPLs调控木质素合成的分子机制研究
miR156-targeted PvSPL转录因子调控柳枝稷分蘖发育的分子机制